Project
The Choice Agenda is a global forum for advocacy on the latest in HIV prevention research
Discussion, debate, and information sharing has been core to HIV advocacy and activism for over four decades resulting in many hard fought global gains in HIV treatment and prevention.
Today, as we work to make complex science accessible, identify where advocacy and action are needed, and pursue bold national, regional, and international agendas that improve global responses to HIV and prepare to prevention future pandemics, we need a space to come together.
The Choice Agenda provides such a space—it is a new global forum for advocacy on the latest in HIV prevention. With monthly webinars hosting highly-informed discussions with advocates and experts across the field and a moderated listserv of nearly 2000 subscribers from 40 countries, the Choice Agenda platform is serving as an essential space for the HIV prevention community to come together to discuss, debate and chart the way forward.
The Choice Agenda program, and all of its participants take on a wide range of topics. Together, the TCA community drills into critical choices, including the need for short acting, non-systemic, user-controlled options, and a wide range of tailored implementation strategies that must define advocacy, the HIV response, and global health equity at large. Participants are also provided with links to a curation of exceptional resources to support further education and advocacy.
Join in on agenda-setting conversations. Members are encouraged to share their opinions and concerns and contribute to discussions and debates in the space. They can also reach out with suggestions about webinar content and speakers. Reach out to Jim at jimberlypickett@gmail.com to be added to the list.
The Choice Agenda hosts monthly webinars and moderates passionate, highly-informed discussions with advocates and experts across the field. Upcoming events are above on this page. Recordings are available here. Materials from previous events will be posted soon.
Follow along on Twitter via #TheChoiceAgenda and email Jim to join the listserv.
So many interesting threads and important to have a platform where people can voice difficult issues in a frank and challenging way. I am learning so much.
Thank you so much Jim for moderating this forum. I want to nominate Jim to be the next PM for Thailand.
webinar
In a major twist that could potentially result in as much as $1B for equitable PrEP access in the US, the government has just made the decision to appeal last year’s jury verdict in the US v. Gilead case. The Choice Agenda and PrEP4All discussed the origin of US v. Gilead, the reasons for the government appeal, and what the case means for PrEP users in the United States.
webinar
Science and real-world experience continue to demand a re-assessment of our collective understanding of the safety and effectiveness of PrEP options for women, including oral, vaginal ring, and injectable options. For instance, a new paper in the Journal of the American Medical Association by Dr. Jeanne Marrazzo challenges the notion that cisgender women need to be “super-adherers” to achieve protection utilizing oral PrEP. In this webinar, we discussed this important paper and more.
webinar
The Choice Agenda and partners hosted a fascinating discussion about a novel, much-needed HIV prevention research study – HPTN 096 on November 15. Currently in the field, the study addresses social, structural, institutional, and behavioral barriers to HIV prevention and care. Visit the study website here.